Legal Archives - Boston Life Sciences Times

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

April 27, 2026

908 Devices Names Kola Otitoju Chief Business & Strategy Officer, Announces Inducement Grant

April 22, 2026

Bicycle Therapeutics Reports Promising Cancer Drug Data at AACR Meeting

April 20, 2026

THIS WEEK'S STORIES

AstraZeneca’s SAPHNELO Approved in U.S. as Self-Injectable Treatment for Lupus

April 27, 2026

Outcome Capital Names Jaison Ellis Managing Director to Expand Healthcare Advisory Platform

April 23, 2026

Signum Surgical Appoints Mark J. Foley as Chairman to Support Growth of BioHealx Technology

April 23, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Legal

Investors Face May 4 Deadline in Lawsuit Over Boston Scientific Stock Drop

Investors File Securities Fraud Lawsuit Against Boston Scientific Over Electrophysiology Growth Claims

Enveric Biosciences Says Patent Challenge Has Been Withdrawn

Applied Medical Wins Antitrust Jury Verdict Against Medtronic

Federal Court Grants WHOOP Preliminary Injunction Against Lexqi

Most Read

Premier Study Unveils New Tool to Identify High-Risk Pregnancies Earlier

Cerus Signs Four-Year Supply Deal With French Blood Agency for INTERCEPT System

Veradermics Reports Strong Late-Stage Trial Results for Oral Hair Loss Treatment

VGM and Trace Medical Expand Partnership With Exclusive Nationwide Agreement

EDITOR PICKS